A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivo

Angiogenesis ◽  
2009 ◽  
Vol 12 (3) ◽  
pp. 287-296 ◽  
Author(s):  
Kenneth R. LaMontagne ◽  
Jeannene Butler ◽  
Virna B. Borowski ◽  
Angel R. Fuentes-Pesquera ◽  
Jonathan M. Blevitt ◽  
...  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Growth Factor Receptor ◽  
Vascular Endothelial ◽  
Orally Bioavailable ◽  
Endothelial Growth Factor

scholarly journals The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis

2008 ◽  
Vol 68 (12) ◽  
pp. 4754-4762 ◽  
Author(s):  
Caroline A. Heckman ◽  
Tanja Holopainen ◽  
Maria Wirzenius ◽  
Salla Keskitalo ◽  
Michael Jeltsch ◽  
...  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Growth Factor Receptor ◽  
Vascular Endothelial ◽  
Endothelial Growth Factor
Sign in / Sign up

Export Citation Format

Share Document